Greater trochanteric pain syndrome (GTPS) is a common musculoskeletal disorder that affects the hip and can cause pain, tenderness, and stiffness in the area of the greater trochanter. It is a challenging condition to diagnose and treat, and can have a significant impact on a person’s quality of life. This article will provide an overview of GTPS, its symptoms, and potential treatments.
GTPS is a condition that affects the hip and causes pain, tenderness, and stiffness in the area of the greater trochanter. The greater trochanter is a bony prominence located on the outside of the hip, and it is the site of attachment for several muscles and tendons. GTPS is thought to be caused by overuse or repetitive strain of these muscles and tendons, leading to inflammation and pain. It is most common in middle-aged women, but can also affect men and younger people.
The most common symptom of GTPS is pain in the area of the greater trochanter. This pain may be a dull ache or a sharp, burning sensation. It may be worse when lying on the affected side or when walking or running. Other symptoms may include tenderness in the area, stiffness, and decreased range of motion. In some cases, the pain may radiate down the outside of the thigh or up into the lower back.
GTPS can be difficult to diagnose, as its symptoms can be similar to those of other conditions. To make a diagnosis, a doctor will typically start by taking a thorough medical history and performing a physical examination. Imaging tests such as X-rays or MRI scans may also be used to rule out other conditions. In some cases, a doctor may order a nerve conduction study or an electromyography (EMG) to determine if there is nerve involvement.
The treatment of GTPS is typically aimed at reducing pain and inflammation. Non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen or naproxen may be prescribed to reduce inflammation and pain. Physical therapy may also be used to improve flexibility and strength in the affected area. In some cases, a doctor may recommend a corticosteroid injection to reduce inflammation. Surgery is rarely needed, but may be an option for some people.
The best way to prevent the development of GTPS is to avoid activities that can cause overuse or strain in the hip area. Wearing proper shoes and using proper form when exercising can help reduce the risk of developing GTPS. Stretching before and after exercise can also help reduce the risk of developing GTPS. Additionally, regular exercise can help strengthen the muscles and tendons around the hip, which can help reduce the risk of developing GTPS.
GTPS is a common musculoskeletal disorder that can cause pain, tenderness, and stiffness in the area of the greater trochanter. It can be difficult to diagnose and treat, but the symptoms can usually be managed with medication, physical therapy, and lifestyle modifications. Understanding the symptoms, diagnosis, and treatment of GTPS can help people manage their condition and reduce their risk of developing it in the future.
1.
AI-based liquid biopsy shows promise for detecting brain cancer
2.
Obesity linked to subsequent neoplasms in childhood cancer survivors
3.
Reducing social media to an hour a day boosts young people's self-image.
4.
Prostate Cancer Treatment Associated With Long-Term Complications
5.
Olaparib-Abiraterone in mCRPCs Selected by Biomarkers Outperforms Each Agent by Itself.
1.
Beyond the Brain Fog: The Complex Neurological Challenges and Therapeutic Advances
2.
Unlocking the Potential of Lymphocytes: Exploring the Role of These Immune System Cells
3.
Hope in Numbers: Understanding AML Leukemia Survival Rates and Emerging Therapies
4.
7 Subtle Signs of Leukemia: How to Spot the Symptoms Early
5.
Refractory Iron Deficiency Anemia in a Young Adult: Diagnostic Challenges
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
2.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
3.
Current Scenario of Cancer- Q&A Session to Close the Gap
4.
Navigating the Brain Barrier: The CNS Challenge in ALK+ NSCLC
5.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation